Below are brief introductions to chickenpox (varicella) and the chickenpox (varicella) vaccine with links to more information.
Chickenpox (varicella) is an illness caused by the varicella zoster virus, a DNA virus that is part of the herpes virus family and associated with shingles. The virus first presents as a chickenpox infection; however, if the virus reactivates, it will present as a shingles infection.1 Chickenpox is transmitted through direct contact with chickenpox blisters, by inhaling particles from the chickenpox blisters, and possibly from contact with respiratory secretions infected with the virus.2 Symptoms of chickenpox generally begin between 10 and 21 days following exposure to the virus and the illness typically lasts between 5 and 10 days. The varicella virus is found only in humans and outbreaks generally occur between March and May in the United States.3
There are two live virus vaccines for chickenpox licensed for use in the U.S. by the FDA: Varivax,4 a live varicella (chickenpox) virus vaccine manufactured by Merck; and ProQuad (MMRV),5 a live virus vaccine containing measles, mumps, rubella and varicella (chickenpox), also manufactured by Merck. There is a higher risk of seizure following MMRV vaccination if this vaccine is administered as the first dose, when compared to the administration of separate doses of MMRII and varicella vaccines.6 The CDC recommends children receive a first dose of chickenpox vaccine between 12 and 15 months and a second dose between 4 and 6 years. The CDC also recommends two doses of chickenpox vaccine be administered 4 to 8 weeks apart to all school-aged students, post-secondary aged students, and all healthy adults who lack immunity to chickenpox.7